453 related articles for article (PubMed ID: 18948614)
1. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study.
Laskowitz DT; Kasner SE; Saver J; Remmel KS; Jauch EC;
Stroke; 2009 Jan; 40(1):77-85. PubMed ID: 18948614
[TBL] [Abstract][Full Text] [Related]
2. Novel diagnostic test for acute stroke.
Lynch JR; Blessing R; White WD; Grocott HP; Newman MF; Laskowitz DT
Stroke; 2004 Jan; 35(1):57-63. PubMed ID: 14671250
[TBL] [Abstract][Full Text] [Related]
3. Discriminative capacity of biomarkers for acute stroke in the emergency department.
Glickman SW; Phillips S; Anstrom KJ; Laskowitz DT; Cairns CB
J Emerg Med; 2011 Sep; 41(3):333-9. PubMed ID: 20417054
[TBL] [Abstract][Full Text] [Related]
4. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.
Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J
Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979
[TBL] [Abstract][Full Text] [Related]
5. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
[TBL] [Abstract][Full Text] [Related]
6. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.
Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S
Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364
[TBL] [Abstract][Full Text] [Related]
7. Plasma biomarkers in the diagnosis of acute ischemic stroke.
Kim MH; Kang SY; Kim MC; Lee WI
Ann Clin Lab Sci; 2010; 40(4):336-41. PubMed ID: 20947807
[TBL] [Abstract][Full Text] [Related]
8. A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department.
Montaner J; Mendioroz M; Ribó M; Delgado P; Quintana M; Penalba A; Chacón P; Molina C; Fernández-Cadenas I; Rosell A; Alvarez-Sabín J
J Intern Med; 2011 Aug; 270(2):166-74. PubMed ID: 21198992
[TBL] [Abstract][Full Text] [Related]
9. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.
Montaner J; Mendioroz M; Delgado P; García-Berrocoso T; Giralt D; Merino C; Ribó M; Rosell A; Penalba A; Fernández-Cadenas I; Romero F; Molina C; Alvarez-Sabín J; Hernández-Guillamon M
J Proteomics; 2012 Aug; 75(15):4758-65. PubMed ID: 22343074
[TBL] [Abstract][Full Text] [Related]
10. Early biomarkers of stroke.
Reynolds MA; Kirchick HJ; Dahlen JR; Anderberg JM; McPherson PH; Nakamura KK; Laskowitz DT; Valkirs GE; Buechler KF
Clin Chem; 2003 Oct; 49(10):1733-9. PubMed ID: 14500614
[TBL] [Abstract][Full Text] [Related]
11. Serum protein S100β is a diagnostic biomarker for distinguishing posterior circulation stroke from vertigo of nonvascular causes.
Purrucker JC; Herrmann O; Lutsch JK; Zorn M; Schwaninger M; Bruckner T; Auffarth GU; Veltkamp R
Eur Neurol; 2014; 72(5-6):278-84. PubMed ID: 25323105
[TBL] [Abstract][Full Text] [Related]
12. Use of the Triage Stroke Panel in a neurologic emergency service.
Sibon I; Rouanet F; Meissner W; Orgogozo JM
Am J Emerg Med; 2009 Jun; 27(5):558-62. PubMed ID: 19497461
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.
Foerch C; Wunderlich MT; Dvorak F; Humpich M; Kahles T; Goertler M; Alvarez-Sabín J; Wallesch CW; Molina CA; Steinmetz H; Sitzer M; Montaner J
Stroke; 2007 Sep; 38(9):2491-5. PubMed ID: 17673718
[TBL] [Abstract][Full Text] [Related]
14. The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Wang L; Wei C; Deng L; Wang Z; Song M; Xiong Y; Liu M
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1653-1665. PubMed ID: 29598905
[TBL] [Abstract][Full Text] [Related]
15. A biomarker panel: an additional resource in acute stroke evaluation?
Kimura T; Nishikawa T
Minerva Anestesiol; 2013 Jul; 79(7):711-2. PubMed ID: 23558768
[No Abstract] [Full Text] [Related]
16. Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke.
Kavalci C; Genchallac H; Durukan P; Cevik Y
Bratisl Lek Listy; 2011; 112(7):398-401. PubMed ID: 21744736
[TBL] [Abstract][Full Text] [Related]
17. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.
Undén J; Strandberg K; Malm J; Campbell E; Rosengren L; Stenflo J; Norrving B; Romner B; Lindgren A; Andsberg G
J Neurol; 2009 Jan; 256(1):72-7. PubMed ID: 19221847
[TBL] [Abstract][Full Text] [Related]
18. Use of biomarkers in triage of patients with suspected stroke.
Vanni S; Polidori G; Pepe G; Chiarlone M; Albani A; Pagnanelli A; Grifoni S
J Emerg Med; 2011 May; 40(5):499-505. PubMed ID: 19217237
[TBL] [Abstract][Full Text] [Related]
19. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study.
Jauch EC; Lindsell C; Broderick J; Fagan SC; Tilley BC; Levine SR;
Stroke; 2006 Oct; 37(10):2508-13. PubMed ID: 16960091
[TBL] [Abstract][Full Text] [Related]
20. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM
Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
